9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
[Síguenos ahora también en WhatsApp. Da clic aquí] European health authorities on Friday called for stronger control measures after the first case of mpox was detected in Sweden yesterday.
[Síguenos ahora también en WhatsApp. Da clic aquí]
European health authorities on Friday called for stronger control measures after the first case of mpox was detected in Sweden yesterday. (formerly known as monkeypox) from Africa and thereby reduce the risk of large-scale transmission of infection.
The European Centre for Disease Prevention and Control (ECDC) noted in a statement today. The updated risk assessment shows that it is “very likely” that there will be more imported cases of MPCS.but ruled out that the infection could continue if action was taken quickly.
“The likelihood of sustained transmission in Europe is very low if imported cases are diagnosed quickly and control measures are put in place.”noted the European Union (EU) infection control body, based in Stockholm.
ECDC called for effective surveillance, laboratory testing, epidemiological investigation and contact tracing – initiatives similar to those called for by the World Health Organization (WHO).
“The detection of the first mpox clade 1b infection in Sweden highlights the need for affected countries to work together to combat the virus”– warned WHO Secretary-General Tedros Adhanom Ghebreyesus on his account on the social network X.
Tedros called apply “lessons learned” from previous international public health emergencies and called for increased surveillance and “working together to understand transmission” by sharing information and tools such as vaccines.
Hans Kluge, Director of WHO/Europe, commented on the same social network:
I also call on governments, health authorities and the general public not to stigmatize or discriminate against individuals or communities affected by AIDS.
Kluge recalled that 2022 mpox outbreak ‘swiftly stopped’ through collaboration with affected communities, taking appropriate protective measures and creating a ‘caring’ environment.
Danish pharmaceutical company Bavarian Nordic announced today that asked the European Medicines Agency (EMA) to extend the authorisation for the use of the smallpox vaccine in adolescents.the only one approved by the competent authorities of Europe and the USA.
“Interim results from clinical trials do not show a lower immune response to vaccines in adolescents and have similar safety profiles compared to adults.”which supports the extension of the current authorisation in Europe beyond 2024,” the company said in a statement.
Bavarian Nordic reminded that although its use is currently only indicated for people over 18 years of age, The vaccine has already received emergency authorization from the FDA during the global mpox epidemic in 2022. apply it to people from 12 to 17 years old.
The Danish firm said it was also preparing another study to evaluate the use of the vaccine in children aged 2 to 12 years, partly funded by the Coalition for Epidemic Preparedness Innovations and set to begin this year in the Republic of Congo and Uganda.
EFE
Source: Aristegui Noticias
As an experienced journalist and author, Mary has been reporting on the latest news and trends for over 5 years. With a passion for uncovering the stories behind the headlines, Mary has earned a reputation as a trusted voice in the world of journalism. Her writing style is insightful, engaging and thought-provoking, as she takes a deep dive into the most pressing issues of our time.
